Lactation on Breast Tumorigenesis
Lactation on Breast Tumorigenesis
批准号:
10668820
负责人:
Yi Li
金额:
$55.33万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-05-01 至 2028-04-30
关键词:
20 year oldAgeAge YearsAlveolarAlveolar CellAmericanAtypiaAutomobile DrivingBiological MarkersBreastBreast Cancer Risk FactorBreast FeedingCellsChildbirthClinical TrialsComplementCorrelative StudyDataDiagnosisERBB2 geneEpidemiologyEstrogen receptor positiveEstrogensFirst BirthsGenomicsGlycine decarboxylaseHumanHyperplasiaInfantIntraductal HyperplasiaKnock-outKnowledgeLactationLengthLesionLobularMalignant NeoplasmsMammary NeoplasmsMammary glandMediatingMediatorMethodsModelingMolecularMothersMusNulliparityOncogenesPIK3CA genePathway interactionsPopulationPregnancyPremalignant CellPropertyProteinsProteomicsRattusReportingReproductionResearchRiskRodent ModelRoleSpecific qualifier valueSpecimenStat5 proteinStudy modelsTestingTimeVirusWomanWorkage relatedbreast lesionbreast tumorigenesiscancer riskcarcinogenesischild bearingdigitalepidemiology studyinhibitorinsightmalignant breast neoplasmmammarymouse modelnew therapeutic targetnovelolder womenoverexpressionparitypremalignantprogenitorreproductivereproductive hormonetranscriptome sequencingtriple-negative invasive breast carcinomatumortumorigenesisyoung woman
中文摘要
流行病学研究表明,25岁之前生育第一胎可降低乳腺癌(BCa)风险,而25岁之前生育第一胎可降低乳腺癌(BCa)风险。
35岁以后的第一次生育会增加BCa风险。第一胎对BCa风险的这种年龄依赖性影响通常是
由于怀孕本身,少得多的考虑往往伴随着哺乳。在年轻女性中,
有充分的证据表明,怀孕本身和哺乳都会降低BCa风险。然而,相对贡献
尚未研究妊娠与哺乳对与晚期生殖相关的BCa风险增加的影响
无论是流行病学上还是实验上。任何年龄的哺乳本身都被认为是有益的
母亲和婴儿,并鼓励。然而,我们的初步数据表明,
促使先前存在的早期病变进展为癌症。鉴于越来越多的妇女,
选择将第一次怀孕推迟到35岁或35岁以上,因为早期病变累积的可能性很小。
如果我们的假设得到证实,对这些妇女有重要而直接的影响,
被诊断出患有乳腺癌的女性他们可以利用这些知识做出明智的决定,
他们是否会母乳喂养,以及母乳喂养的时间。我们将测试这一假设,并研究潜在的分子
具体目标有三个:一是具体目标。为了进一步阐明妊娠与哺乳对
乳腺癌的风险既存乳腺早期病变。具体目标2。研究哺乳如何调节
癌前病变的进展路径。具体目标3。为了进一步阐明哺乳诱导的
癌前病变
英文摘要
Epidemiological studies have demonstrated that a first birth before age 25 lowers breast cancer (BCa) risk, while a
first birth after age 35 increases BCa risk. This age-dependent impact of first birth on BCa risk is generally
attributed to the pregnancy itself, with much less consideration for the lactation that often ensues. In young women,
evidence is strong that both pregnancy itself and lactation decrease BCa risk. However, the relative contribution of
pregnancy vs. lactation to increased BCa risk associated with a late-age reproduction has not been studied
rigorously, either epidemiologically or experimentally. Lactation itself at any age is assumed to be beneficial to both
mothers and infants, and is encouraged. However, our preliminary data suggest the hypothesis that lactation
instigates preexistent early lesions to progress to cancer. Given the increasingly large population of women who
choose to delay their first pregnancy to age 35 or older when the chance of having accumulated early lesions is
heightened, our hypothesis, if proven, has important and immediate implications for these women and especially
for women have been diagnosed with atypia. They can use this knowledge to make informed decisions regarding
whether and how long they will breastfeed. We will test this hypothesis and study the underlying molecular
mechanism by pursuing three aims: Specific Aim 1. To further elucidate the impact of pregnancy vs. lactation on
breast cancer risk of preexistent mammary early lesions. Specific Aim 2. To investigate how lactation modulates
the progression path of precancerous lesions. Specific Aim 3. To further elucidate lactation-induced changes in
precancerous lesions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mutating E-cadherin in rats to model lobular breast cancer
-
批准号:10830164
-
项目类别:
-
资助金额:$17.46万
-
财政年份:2022
-
负责人:Yi Li
-
依托单位:
Next Generation Rat Models of ER+ Breast Cancer
-
批准号:10591512
-
项目类别:
-
资助金额:$58.52万
-
财政年份:2022
-
负责人:Yi Li
-
依托单位:
Next Generation Rat Models of ER+ Breast Cancer
-
批准号:10464834
-
项目类别:
-
资助金额:$61.22万
-
财政年份:2022
-
负责人:Yi Li
-
依托单位:
New Statistical Methods for Modelling Cancer Outcomes
-
批准号:10542801
-
项目类别:
-
资助金额:$33.61万
-
财政年份:2021
-
负责人:Yi Li
-
依托单位:
New Statistical Methods for Modelling Cancer Outcomes
-
批准号:10317123
-
项目类别:
-
资助金额:$34.03万
-
财政年份:2021
-
负责人:Yi Li
-
依托单位:
CSF Clearance in Sporadic Alzheimer's Disease
-
批准号:10606516
-
项目类别:
-
资助金额:$75.94万
-
财政年份:2019
-
负责人:Yi Li
-
依托单位:
CSF Clearance in Sporadic Alzheimer's Disease
-
批准号:9981182
-
项目类别:
-
资助金额:$82.77万
-
财政年份:2019
-
负责人:Yi Li
-
依托单位:
CSF Clearance in Sporadic Alzheimer's Disease
-
批准号:9993210
-
项目类别:
-
资助金额:$80.98万
-
财政年份:2019
-
负责人:Yi Li
-
依托单位:
CSF Clearance in Sporadic Alzheimer's Disease
-
批准号:10390277
-
项目类别:
-
资助金额:$77.94万
-
财政年份:2019
-
负责人:Yi Li
-
依托单位:
The Regulation of Gene Expression via Epigenetic Mechanisms during Onset of Obesity, Type 2 Diabetes
-
批准号:9270051
-
项目类别:
-
资助金额:$10.32万
-
财政年份:2016
-
负责人:Yi Li
-
依托单位:
The Regulation of Gene Expression via Epigenetic Mechanisms during Onset of Obesity, Type 2 Diabetes
-
批准号:8999852
-
项目类别:
-
资助金额:$9.57万
-
财政年份:2016
-
负责人:Yi Li
-
依托单位:
The cell of origin of breast cancer metastasis
-
批准号:9188064
-
项目类别:
-
资助金额:$20.68万
-
财政年份:2015
-
负责人:Yi Li
-
依托单位:
Integrated Analysis of High Throughput Cancer Genomic Data
-
批准号:8401160
-
项目类别:
-
资助金额:$11.63万
-
财政年份:2011
-
负责人:Yi Li
-
依托单位:
Integrated Analysis of High Throughput Cancer Genomic Data
-
批准号:8117960
-
项目类别:
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:Yi Li
-
依托单位:
Integrated Analysis of High Throughput Cancer Genomic Data
-
批准号:8369374
-
项目类别:
-
资助金额:$20.2万
-
财政年份:2011
-
负责人:Yi Li
-
依托单位:
Oncogene susceptibility: physiological state & breast cell differentiation
-
批准号:8208111
-
项目类别:
-
资助金额:$30.9万
-
财政年份:2010
-
负责人:Yi Li
-
依托单位:
Oncogene susceptibility: physiological state & breast cell differentiation
-
批准号:8606424
-
项目类别:
-
资助金额:$29.97万
-
财政年份:2010
-
负责人:Yi Li
-
依托单位:
Oncogene susceptibility: physiological state & breast cell differentiation
-
批准号:8444583
-
项目类别:
-
资助金额:$29.04万
-
财政年份:2010
-
负责人:Yi Li
-
依托单位:
Oncogene susceptibility: physiological state & breast cell differentiation
-
批准号:8045518
-
项目类别:
-
资助金额:$30.9万
-
财政年份:2010
-
负责人:Yi Li
-
依托单位:
Oncogene susceptibility: physiological state & breast cell differentiation
-
批准号:7889225
-
项目类别:
-
资助金额:$31.85万
-
财政年份:2010
-
负责人:Yi Li
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: